N/A N=7 Digital Cognitive-Behavioral Therapy for Insomnia in Spanish Speaking Latinas/os (Dormir Mejor Study)
Insomnia
Primary: Change in Mean Insomnia Severity Index Score (ISI) — -6.7; -3.9 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=5,217 An Evaluation of the Team Birth Project
Pregnancy Complications · Cesarean Section Complications · Maternal Complication of Pregnancy
Primary: Percent of Clinicians Recommending TeamBirth Project — 254; 83; 25; 13 Participants
N/A N=30 Buoy Electrolyte Study on Hydration Status of Active Men and Women
Dehydration · Electrolyte Imbalance · Electrolyte Depletion
Primary: Net Fluid Balance — 0.28; 0.05; 0.03 Liter
N/A N=38 Local and Systemic Antimicrobials in Non-surgical Periodontal Therapy
Periodontitis
Primary: Change in Pocket Probing Depth (PPD) — 3.932; 4.082; 3.253; 3.294 mm
Phase 2 N=86 SIKAMIC (SIklos on Kidney Function and AlbuMInuria Clinical Trial)
Sickle Cell Disease
Primary: Number of Patients Achieving at Least a 30% Decrease in ACR Baseline Value — 18; 15 Participants
N/A N=42 Novel Device to Assess Endotracheal Tube Migration
Mechanically Ventilated Patients Admitted to a MICU
Primary: Endotracheal Tube Displacement Bias Measured by a Novel Device (AirWave) Compared to CXR — -0.06; -0.29; 0.39 cm
N/A N=474 Tiny Cargo, Big Deal! An ED-Based Study of Child Passenger Safety Behaviors
Accident, Traffic
Primary: Number of Participants With Guideline Adherent Child Passenger Safety Behaviors at 6 Months — 38; 131 Participants — p=0.006
Phase 2 N=108 REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients
Neurotrophic Keratitis
Primary: Corneal Healing — 4; 2; 1; 2 Participants
N/A N=56 The Effect of Acute Intermittent Hypoxia on Motor Learning
Incomplete Spinal Cord Injury
Primary: Change in Corticospinal Excitability — 0.528; 0.132 mV*percentage of RMT — p=0.0098
Phase 4 N=864,493 Azithromycin for Child Survival in Niger: Mortality and Resistance Trial
Mortality · Resistance Bacterial · Child, Only
Primary: All-cause Mortality (1-59 Months Old) — 13.8; 11.9; 13.9 deaths per 1,000 person-years
N/A N=62 Impact of Vertigoheel® on Patients Suffering From Bilateral Vestibulopathy and Functional Dizziness
Vertigo · Functional Dizziness · Bilateral Vestibulopathy
Primary: Dizziness Handicap Inventory — -12.0; -13.2 score on a scale
N/A N=329 Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Coronary Artery Disease · Mitral Valve Regurgitation · Mitral Valve Incompetence
Primary: Subject's Rate of Objective Performance Criteria Per ISO 5840-2005 - Total Number of Late Adverse Events (by Category) Divided by Late Patient Years (Expressed as a…
Phase 4 N=1,151 Lowering Events in Non-proliferative Retinopathy in Scotland
Diabetic Retinopathy
Primary: Number of Participants With Progression to Referable Diabetic Retinopathy or Maculopathy, or Treatment — 131; 168 Participants — p=0.006
N/A N=163 Remote Glucose Monitoring System in Hospitalized Patients With Diabetic Ketoacidosis (DKA)
Diabetic Ketoacidosis
Primary: Time to Resolution of Metabolic Acidosis — 12.84; 12.02 hours
Phase 3 N=270 A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia.
Hyperkalemia
Primary: Least Square Mean S-K Level on Days 8-29 — 4.859; 4.440; 5.225 mmol/L — p=<0.001